P.A.R.K.S. Novi Sad – A Science-Based Autologous Stem Cell Approach Opens New Perspectives for Patients with Neurological Disorders

avivteamdoo
Nov 21
3 min read

Feature Report & Scientific Overview

At a time when medicine is experiencing one of the most dynamic eras of innovation, a healthcare institution in Serbia is drawing significant attention from both the public and the scientific community. The P.A.R.K.S. Special Hospital in Novi Sad has become a regional center for regenerative medicine, built on science, clinical precision, and high standards of patient safety.

Scientific Transparency — The Foundation of Trust

Unlike many centers worldwide that offer regenerative therapies with limited scientific disclosure, P.A.R.K.S. insists on full transparency. One of the leading scientific figures behind the program is Professor Dr. Dušan Marić, whose extensive research and publications are openly available on ResearchGate. This allows patients and families to study the scientific basis of the therapies being provided.

“Every therapeutic protocol we use is based on years of empirical work and international scientific literature. Our obligation is to provide patients with science, not just outcomes,” says Prof. Marić.

His published work focuses on the application of autologous stem cells (including BMAC — bone marrow aspirate concentrate) for various neurological conditions, such as neuroinflammatory processes, cerebral palsy, autism, and neurodegenerative diseases.

Inside the Hospital — A Reporter’s Perspective

Upon entering P.A.R.K.S., it becomes clear that this is a clinic where advanced technology, research, and patient care form an inseparable whole. The surgical team, physiatrists, and physiotherapists work in full synchrony — functioning as a highly coordinated, multidisciplinary unit.

“Our work doesn’t end with the stem cell procedure. Properly guided physical and rehabilitative therapy is essential for achieving the best results,” explains one of the clinic’s physiatrists.

The hospital also houses a dedicated orthopedic polyclinic, providing continuous support for patients in recovery, particularly those with motor and functional impairments.

Who Are These Therapies Intended For?

P.A.R.K.S. performs autologous stem cell procedures for conditions such as:

• autism spectrum disorders

• multiple sclerosis

• ALS

• cerebral palsy

• dementia

• Alzheimer’s disease

• Parkinson’s disease

While regenerative therapies are still considered innovative and, in some areas, experimental worldwide, the number of studies pointing to their potential continues to grow steadily.

Safety First — Strict Medical Protocols

Journalists visiting the clinic consistently highlight one detail: every procedure begins with an extensive, detailed consultation with patients and their families.

“Patient safety is our absolute priority. All procedures are conducted according to international standards, with full informed consent. Nothing is hidden — every risk and benefit is clearly explained,” notes a member of the surgical team.

Patients undergo laboratory diagnostics, neurological assessments, physical evaluations, and individualized treatment planning — a level of comprehensive care not commonly available in many regional healthcare systems.

Results in Practice — The Voice of Patients

On the clinic’s official website, numerous patient testimonials describe positive changes following treatment. Parents of children with developmental challenges, individuals with MS, and patients with motor disorders report improvements in:

• attention and communication

• motor skills

• general condition

• daily functioning

• stability and energy levels

One mother of a child with autism explains:

“After the treatment, we noticed better engagement with the environment, improved eye contact, and fewer episodes of frustration. Most importantly, our child is now much more responsive during school activities.”

Internal Data and Treatment Success Rates

Based on the clinic’s internal clinical observations, the P.A.R.K.S. team reports that the estimated improvement rate for patients with neurodevelopmental and neurodegenerative conditions ranges between 75% and 80%, depending on diagnosis, age, and post-treatment compliance.

“Stem cells are not a magic cure — but when combined with our protocols and rehabilitation, we see outcomes that genuinely improve patients’ lives,” explains Prof. Marić.